177 related articles for article (PubMed ID: 11145893)
1. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
Kumar A; Buch S; Foresman L; Bischofberger N; Lifson JD; Narayan O
Virology; 2001 Jan; 279(1):97-108. PubMed ID: 11145893
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment.
Spring M; Stahl-Hennig C; Stolte N; Bischofberger N; Heeney J; ten Haaft P ; Tenner-Ràcz K; Ràcz P; Lorenzen D; Hunsmann G; Dittmer U
Virology; 2001 Jan; 279(1):221-32. PubMed ID: 11145904
[TBL] [Abstract][Full Text] [Related]
3. Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.
Smith MS; Foresman L; Lopez GJ; Tsay J; Wodarz D; Lifson JD; Page A; Wang C; Li Z; Adany I; Buch S; Bischofberger N; Narayan O
Virology; 2000 Nov; 277(2):306-15. PubMed ID: 11080478
[TBL] [Abstract][Full Text] [Related]
4. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
[TBL] [Abstract][Full Text] [Related]
6. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.
Kumar R; Orsoni S; Norman L; Verma AS; Tirado G; Giavedoni LD; Staprans S; Miller GM; Buch SJ; Kumar A
Virology; 2006 Oct; 354(1):192-206. PubMed ID: 16876224
[TBL] [Abstract][Full Text] [Related]
7. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376
[TBL] [Abstract][Full Text] [Related]
8. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
[TBL] [Abstract][Full Text] [Related]
9. Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy.
Verhoeven D; Sankaran S; Dandekar S
J Med Primatol; 2007 Aug; 36(4-5):219-27. PubMed ID: 17669210
[TBL] [Abstract][Full Text] [Related]
10. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
Uberla K; Rosenwirth B; Ten Haaft P; Heeney J; Sutter G; Erfle V
J Med Primatol; 2007 Feb; 36(1):2-9. PubMed ID: 17359459
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques.
Rosenwirth B; ten Haaft P; Bogers WM; Nieuwenhuis IG; Niphuis H; Kuhn EM; Bischofberger N; Heeney JL; Uberla K
J Virol; 2000 Feb; 74(4):1704-11. PubMed ID: 10644340
[TBL] [Abstract][Full Text] [Related]
13. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
[TBL] [Abstract][Full Text] [Related]
14. Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.
Van Rompay KK; McChesney MB; Aguirre NL; Schmidt KA; Bischofberger N; Marthas ML
J Infect Dis; 2001 Aug; 184(4):429-38. PubMed ID: 11471100
[TBL] [Abstract][Full Text] [Related]
15. Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin.
Rasmussen RA; Montefiori DC; Robinson HL; McClure HM; Ruprecht RM
J Infect Dis; 2001 Dec; 184(12):1603-7. PubMed ID: 11740737
[TBL] [Abstract][Full Text] [Related]
16. The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P.
Zhang ZQ; Schleif WA; Casimiro DR; Handt L; Chen M; Davies ME; Liang X; Fu TM; Tang A; Wilson KA; McElhaugh M; Carella A; Tan C; Connolly B; Hill S; Klein H; Emini EA; Shiver JW
Virology; 2004 Mar; 320(1):75-84. PubMed ID: 15003864
[TBL] [Abstract][Full Text] [Related]
17. Induction of immune response in macaque monkeys infected with simian-human immunodeficiency virus having the TNF-alpha gene at an early stage of infection.
Shimizu Y; Miyazaki Y; Ibuki K; Suzuki H; Kaneyasu K; Goto Y; Hayami M; Miura T; Haga T
Virology; 2005 Dec; 343(2):151-61. PubMed ID: 16169034
[TBL] [Abstract][Full Text] [Related]
18. Th17 cells, HIV and the gut mucosal barrier.
Dandekar S; George MD; Bäumler AJ
Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
[TBL] [Abstract][Full Text] [Related]
19. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.
Monceaux V; Viollet L; Petit F; Cumont MC; Kaufmann GR; Aubertin AM; Hurtrel B; Silvestri G; Estaquier J
J Virol; 2007 Dec; 81(24):13865-75. PubMed ID: 17898067
[TBL] [Abstract][Full Text] [Related]
20. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]